Role of GSA Scintigraphy to predict liver failure after perihilar cholangiocarcinoma surgery

Role of GSA Scintigraphy to predict liver failure after perihilar cholangiocarcinoma surgery - GSA Scintigraphy and PHLF

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040384

Enrollment

183

Registered

2020-05-13

Start date

2020-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perihilar cholangiocarcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with perihilar cholangiocarcinoma surgery in Hokkaido University (Surg II or Gastroenterological surgery II),

Exclusion criteria

Exclusion criteria: Data missing

Design outcomes

Primary

Measure	Time frame
Liver failure-related death	—

Secondary

Measure	Time frame
Incidence of liver failure	—

Countries

Japan

Contacts

Public ContactTakehiro Noji

Hokkaido University Hospital Gastroenterological surgery II

drnoji@med.hokudai.ac.jp011-706-7714

Outcome results